Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ZTS — Zoetis Inc.

CIK 861177 NEW YORK, NY

Position in ZTS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$519,929,066
+$38,501,490 QoQ
Shares Held
4,398,351
+14.9% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 56.18414719516473.ToString("F0")% Shared 0.ToString("F0")% None 43.81585280483527.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (56.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page
4,398,351 $519,929,066

All Filings in ZTS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $519,929,066 4,398,351
2025-12-31 $481,427,576 3,826,320
2025-09-30 $585,903,904 4,004,264
2025-06-30 $806,999,449 5,174,732
2025-03-31 $700,206,554 4,252,697
2024-12-31 $664,522,709 4,078,578
2024-09-30 $761,221,185 3,896,106
2024-06-30 $641,703,129 3,701,564
2024-03-31 $463,816,789 2,741,072
2023-12-31 $550,603,873 2,789,704
2023-09-30 $463,404,074 2,663,548
2023-06-30 $432,109,498 2,509,201
2023-03-31 $417,631,410 2,509,201
2022-12-31 $393,991,023 2,688,441
2022-09-30 $362,174,147 2,442,337
2022-06-30 $428,382,190 2,492,188
2022-03-31 $449,679,836 2,384,431
2021-12-31 $919,218,054 3,766,824
2021-09-30 $1,021,447,415 5,261,396
2021-06-30 $764,024,187 4,099,722
2021-03-31 $663,768,747 4,214,940
2020-12-31 $608,797,541 3,678,535
2020-09-30 $801,943,949 4,849,392
2020-06-30 $659,918,994 4,815,521
2020-03-31 $581,835,818 4,943,800